Provided it has been known to suppress inflammation in many disease processes, including endotoxin shock, Parkinson’s disease and SAH37, 38, 39, some of which are mediated through PAR activation40, it is not surprising that the suppression of microglial cell PAR-1 has neuroprotective effects. This evidence concerns the gene F2R and Parkinson disease.